• Dicloxacillin’s Intracellular and Extracellular Activity Aga

  2026-04-20

  This article reviews a pivotal study that rigorously investigates the intra- and extracellular efficacy of dicloxacillin against Staphylococcus aureus using both in vitro macrophage models and in vivo murine peritonitis models. The findings clarify the pharmacodynamic predictors of efficacy and inform optimized use of β-lactam antibiotics in Gram-positive infection research.

• SGI-1027 and Everolimus Synergy: Inducing Apoptosis via Lyso

  2026-04-20

  This article examines a recent study demonstrating that the DNMT1 inhibitor SGI-1027, in combination with the mTOR inhibitor everolimus, induces both apoptosis and GSDME-dependent pyroptosis in renal cancer cells by triggering lysosomal membrane permeability. The findings highlight a novel, non-apoptotic cytotoxic pathway that addresses resistance to everolimus in advanced renal cell carcinoma, with broad implications for therapeutic strategy development.

• Cefodizime: Applied Workflows for Third-Generation Cephalosp

  2026-04-19

  Cefodizime empowers infection modelers with robust, reproducible protocols for Gram-positive and Gram-negative pathogens—offering β-lactamase stability and immunomodulatory benefits. This article delivers workflow-optimized strategies, troubleshooting insights, and comparative data to elevate microbiology research using APExBIO’s trusted compound.

• Neuroinflammatory CGRP/SP-Piezo2 Axis Drives Trigeminal Allo

  2026-04-18

  Liao et al. (2026) elucidate a neuroinflammatory feedback loop involving the CGRP/SP-Piezo2 axis and Ca2+-dependent signaling, linking ATP-driven pathways to mechanical allodynia in trigeminal neuralgia (TN). These findings identify novel mechanistic targets for modulating tactile hypersensitivity and contribute foundational knowledge for translational pain research.

• Cefodizime: Enhancing Microbiology Research with a Third-Gen

  2026-04-17

  Cefodizime, a third-generation cephalosporin antibiotic, empowers researchers to model respiratory and urinary tract infections with precision, thanks to its robust broad-spectrum and immunomodulatory properties. Learn how APExBIO's research-grade Cefodizime advances experimental workflows, delivers reliable resistance profiling, and addresses key troubleshooting challenges in infectious disease studies.

• Cefodizime in Antibacterial Resistance Surveillance: Advance

  2026-04-16

  Explore the advanced role of Cefodizime, a third-generation cephalosporin antibiotic, in resistance surveillance and infection control. This article uniquely bridges clinical resistance data with research strategies, empowering informed assay decisions.

• Novobiocin: Aminocoumarin Antibiotic Workflows & Innovations

  2026-04-15

  Novobiocin stands out as a multifunctional aminocoumarin antibiotic, empowering researchers with precision in antibacterial, antiparasitic, and antiviral assays. This article translates breakthrough findings into actionable protocols and troubleshooting strategies for advanced resistance and cell biology research.

• Ultrasound-Triggered Piezo-Nanoplatforms for Non-Invasive Ep

  2026-04-14

  This article examines a recent study that introduces a biomimetic piezoelectric nanoplatform for non-invasive, ultrasound-triggered neuromodulation in epilepsy treatment. The platform combines local electrical stimulation and antiepileptic drug delivery, offering a synergistic, minimally invasive approach that addresses several limitations of conventional therapies.

• Cefodizime: Third-Generation Cephalosporin Antibiotic in Res

  2026-04-13

  Cefodizime stands apart as a third-generation cephalosporin antibiotic, combining robust β-lactamase stability with immunomodulatory effects for advanced microbiology workflows. This guide translates clinical and bench research into actionable protocols, comparative insights, and troubleshooting strategies for researchers modeling complex bacterial infections.

• NMDA-Driven Excitotoxicity: Strategic Insights for Translati

  2026-04-12

  This article provides translational researchers with a mechanistic deep-dive into NMDA (N-Methyl-D-aspartic acid)-induced excitotoxicity, linking rigorous experimental design to disease modeling, with actionable guidance for leveraging APExBIO’s high-purity NMDA in neurodegenerative research. Drawing on recent breakthroughs in glaucoma and ferroptosis, we highlight protocol optimization, evidence-backed parameters, and strategic frontiers in biomarker discovery and therapeutic innovation.

• Macrophage EP4 Deficiency Accelerates Atherosclerosis via CD

  2026-04-12

  This study uncovers how the loss of EP4 in macrophages intensifies atherosclerosis by upregulating CD36-dependent lipid uptake and promoting M1 polarization. The findings highlight a key mechanistic link between prostaglandin signaling, foam cell formation, and plaque instability, providing a foundation for future therapeutic strategies targeting macrophage polarization in cardiovascular disease.

• Meropenem: Optimizing β-Lactam Carbapenem Use in Resistance

  2026-04-11

  Meropenem stands as an ultra-broad-spectrum β-lactam antibiotic carbapenem, uniquely suited for modeling and overcoming antimicrobial resistance in Gram-negative and Gram-positive pathogens. This article unpacks advanced experimental workflows, troubleshooting, and protocol parameters that elevate Meropenem’s impact in translational research.

• Dabigatran etexilate: Direct Thrombin Inhibitor in Coagulati

  2026-04-11

  Dabigatran etexilate, a potent oral direct thrombin inhibitor, streamlines in vitro and in vivo anticoagulant research with high selectivity and predictable effects. This guide details optimized workflows, troubleshooting, and protocol parameters, enabling reproducible results for studies in atrial fibrillation and stroke prevention.

• Cefodizime (SKU BA1050): Reliable Cephalosporin for Advan...

  2026-04-10

  This expert article addresses persistent laboratory challenges in antimicrobial activity assays and infectious disease models, highlighting how Cefodizime (SKU BA1050) from APExBIO delivers reproducible, data-driven solutions. Drawing from recent literature and real-world scenarios, the discussion covers antibiotic resistance, assay optimization, and product selection for rigorous microbiology research.

• Hexetidine (NSC-17764): Broad-Spectrum Antimicrobial for ...

  2026-04-09

  Hexetidine (NSC-17764) empowers researchers with a versatile, broad-spectrum antimicrobial agent, uniquely effective across Gram-positive and Gram-negative bacteria and Candida albicans. Its synergy with copper ions and robust performance in biofilm inhibition assays make it a go-to compound for advanced oral infection studies and dental plaque management.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page